IDEXX Laboratories Net Profit Margin 2010-2025 | IDXX
Current and historical net profit margin for IDEXX Laboratories (IDXX) from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue. IDEXX Laboratories net profit margin for the three months ending June 30, 2025 was .
| IDEXX Laboratories Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-06-30 | $4.04B | $0.99B | 24.42% |
| 2025-03-31 | $3.93B | $0.90B | 22.76% |
| 2024-12-31 | $3.90B | $0.89B | 22.78% |
| 2024-09-30 | $3.85B | $0.87B | 22.54% |
| 2024-06-30 | $3.79B | $0.85B | 22.35% |
| 2024-03-31 | $3.73B | $0.87B | 23.27% |
| 2023-12-31 | $3.66B | $0.85B | 23.07% |
| 2023-09-30 | $3.59B | $0.82B | 22.90% |
| 2023-06-30 | $3.52B | $0.79B | 22.50% |
| 2023-03-31 | $3.43B | $0.70B | 20.37% |
| 2022-12-31 | $3.37B | $0.68B | 20.15% |
| 2022-09-30 | $3.34B | $0.67B | 20.05% |
| 2022-06-30 | $3.31B | $0.66B | 20.07% |
| 2022-03-31 | $3.27B | $0.74B | 22.45% |
| 2021-12-31 | $3.22B | $0.75B | 23.17% |
| 2021-09-30 | $3.14B | $0.76B | 24.15% |
| 2021-06-30 | $3.05B | $0.73B | 23.89% |
| 2021-03-31 | $2.86B | $0.67B | 23.57% |
| 2020-12-31 | $2.71B | $0.58B | 21.50% |
| 2020-09-30 | $2.59B | $0.50B | 19.18% |
| 2020-06-30 | $2.47B | $0.46B | 18.59% |
| 2020-03-31 | $2.46B | $0.44B | 17.79% |
| 2019-12-31 | $2.41B | $0.43B | 17.79% |
| 2019-09-30 | $2.35B | $0.42B | 18.04% |
| 2019-06-30 | $2.29B | $0.41B | 17.82% |
| 2019-03-31 | $2.25B | $0.39B | 17.37% |
| 2018-12-31 | $2.21B | $0.38B | 17.04% |
| 2018-09-30 | $2.17B | $0.33B | 15.16% |
| 2018-06-30 | $2.12B | $0.31B | 14.50% |
| 2018-03-31 | $2.05B | $0.28B | 13.84% |
| 2017-12-31 | $1.97B | $0.26B | 13.36% |
| 2017-09-30 | $1.91B | $0.28B | 14.53% |
| 2017-06-30 | $1.86B | $0.26B | 14.07% |
| 2017-03-31 | $1.82B | $0.24B | 13.41% |
| 2016-12-31 | $1.78B | $0.22B | 12.44% |
| 2016-09-30 | $1.73B | $0.21B | 12.29% |
| 2016-06-30 | $1.69B | $0.20B | 11.89% |
| 2016-03-31 | $1.64B | $0.19B | 11.67% |
| 2015-12-31 | $1.60B | $0.19B | 11.99% |
| 2015-09-30 | $1.55B | $0.17B | 11.20% |
| 2015-06-30 | $1.53B | $0.18B | 11.89% |
| 2015-03-31 | $1.51B | $0.18B | 12.07% |
| 2014-12-31 | $1.49B | $0.18B | 12.25% |
| 2014-09-30 | $1.49B | $0.20B | 13.37% |
| 2014-06-30 | $1.44B | $0.19B | 13.38% |
| 2014-03-31 | $1.41B | $0.19B | 13.52% |
| 2013-12-31 | $1.38B | $0.19B | 13.65% |
| 2013-09-30 | $1.34B | $0.19B | 14.00% |
| 2013-06-30 | $1.32B | $0.19B | 14.02% |
| 2013-03-31 | $1.30B | $0.18B | 13.97% |
| 2012-12-31 | $1.29B | $0.18B | 13.76% |
| 2012-09-30 | $1.28B | $0.17B | 13.51% |
| 2012-06-30 | $1.27B | $0.17B | 13.34% |
| 2012-03-31 | $1.25B | $0.17B | 13.37% |
| 2011-12-31 | $1.22B | $0.16B | 13.37% |
| 2011-09-30 | $1.20B | $0.16B | 13.46% |
| 2011-06-30 | $1.17B | $0.16B | 13.48% |
| 2011-03-31 | $1.13B | $0.15B | 12.85% |
| 2010-12-31 | $1.10B | $0.14B | 12.77% |
| 2010-09-30 | $1.09B | $0.14B | 12.48% |
| 2010-06-30 | $1.08B | $0.13B | 12.33% |
| 2010-03-31 | $1.06B | $0.13B | 12.22% |
| 2009-12-31 | $1.03B | $0.12B | 11.93% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $51.272B | $3.898B |
| IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.320B | 22.30 |
| Intuitive Surgical (ISRG) | United States | $168.896B | 70.01 |
| Edwards Lifesciences (EW) | United States | $47.496B | 31.48 |
| Alcon (ALC) | Switzerland | $40.130B | 26.94 |
| IQVIA Holdings (IQV) | United States | $32.096B | 18.14 |
| DexCom (DXCM) | United States | $29.953B | 44.93 |
| Mettler-Toledo (MTD) | United States | $26.475B | 31.42 |
| STERIS (STE) | Ireland | $24.522B | 26.10 |
| Waters (WAT) | United States | $17.538B | 24.09 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.006B | 0.00 |
| Hologic (HOLX) | United States | $14.842B | 16.08 |
| Penumbra (PEN) | United States | $10.410B | 76.05 |
| Globus Medical (GMED) | United States | $8.307B | 19.16 |
| Sysmex ADR (SSMXY) | Japan | $8.057B | 25.60 |
| Masimo (MASI) | United States | $7.741B | 26.05 |
| Teleflex (TFX) | United States | $5.723B | 9.24 |
| Glaukos (GKOS) | United States | $5.455B | 0.00 |
| TransMedics (TMDX) | United States | $4.002B | 60.82 |
| Integer Holdings (ITGR) | United States | $3.786B | 18.89 |
| LivaNova (LIVN) | United Kingdom | $3.084B | 17.65 |
| Alphatec Holdings (ATEC) | United States | $2.394B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.270B | 0.00 |
| Veracyte (VCYT) | United States | $2.251B | 31.10 |
| Artivion (AORT) | United States | $2.064B | 104.14 |
| Nihon Kohden (NHNKY) | Japan | $1.907B | 22.76 |
| Elekta AB (EKTAY) | Sweden | $1.887B | 17.66 |
| Integra LifeSciences Holdings (IART) | United States | $1.159B | 6.64 |
| OPKO Health (OPK) | United States | $1.127B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.066B | 0.00 |
| IRadimed (IRMD) | United States | $0.939B | 45.59 |
| Tandem Diabetes Care (TNDM) | United States | $0.828B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.825B | 0.00 |
| AxoGen (AXGN) | United States | $0.743B | 0.00 |
| SiBone (SIBN) | United States | $0.716B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.586B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.551B | 9.73 |
| OrthoPediatrics (KIDS) | United States | $0.542B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.469B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.452B | 3.63 |
| AngioDynamics (ANGO) | United States | $0.407B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.399B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.383B | 91.17 |
| Mesa Laboratories (MLAB) | United States | $0.378B | 9.62 |
| RxSight (RXST) | United States | $0.350B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.302B | 0.00 |
| NeuroPace (NPCE) | United States | $0.294B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.293B | 20.23 |
| Spectral Diagnostics (EDTXF) | Canada | $0.293B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.286B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.229B | 0.00 |
| 908 Devices (MASS) | United States | $0.226B | 0.00 |
| Neuronetics (STIM) | United States | $0.222B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.222B | 0.00 |
| Inogen (INGN) | United States | $0.214B | 0.00 |
| CVRx (CVRX) | United States | $0.198B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.185B | 0.00 |
| Accuray (ARAY) | United States | $0.177B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.150B | 0.00 |
| LENSAR (LNSR) | United States | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.137B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.132B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.113B | 0.00 |
| InspireMD (NSPR) | United States | $0.102B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.098B | 0.00 |
| Hyperfine (HYPR) | United States | $0.097B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.088B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.071B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.059B | 0.00 |
| Spectral AI (MDAI) | United States | $0.056B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.052B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.039B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.025B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Tenon Medical (TNON) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.31 |